Data / Form D filings / RELEVARE PHARMACEUTICALS INC
RELEVARE PHARMACEUTICALS INC: Form D filings
RELEVARE PHARMACEUTICALS INC, a biotechnology company in Brisbane Queenland, Australia, filed 4 Form D notices with the SEC between 2010 and 2012. The latest, on June 15, 2012, reports $750,000 sold of a $750,000 offering to 1 investor.
Find out what RELEVARE PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- LEVEL 5 CENTRAL PLAZA 2, 66 EAGLE STREET, Brisbane Queenland, Australia, 4001
- Phone
- 61730096850
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1455487
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 15, 2012 | New notice | $750,000 | $750,000 | $0 | 1 | Sep 15, 2011 | sec.gov |
| Mar 2, 2011 | New notice | Indefinite | $0 | Indefinite | 0 | Nov 16, 2010 | sec.gov |
| Apr 20, 2010 | New notice | $3,161,608 | $3,040,682 | $120,926 | 3 | Mar 15, 2010 | sec.gov |
| Apr 20, 2010 | New notice | $5,345,405 | $5,345,405 | $0 | 4 | Sep 21, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| ANDREW HARPUR MICHELL | Director |
Every Form D from the week of Jun 11, 2012 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what RELEVARE PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.